Armata Pharmaceuticals, Inc.
ARMPNYSEAMERICANHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $191.71M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.75$16.34
- Volume (live)
- -
- Avg. volume (3M)
- 288.28K
Armata Pharmaceuticals (ARMP) Stock Price & Financial Analysis
Armata Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.98 - $3.42 |
|---|---|
| 52-Week High | $16.34 |
| 52-Week Low | $2.75 |
| Open | $3.08 |
| Volume (last close) | 154.31K |
| Average Volume (3M) | 288.28K |
| Revenue (TTM) | 3.30M |
|---|---|
| Net Income (TTM) | -192.18M |
| Free Cash Flow (TTM) | -25.79M |
| EPS (TTM) | −$4.49 |
| Profit Margin | -5825.34% |
| Operating Margin | -1069.54% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 191.71M |
|---|---|
| Shares Outstanding | 62.04M |
| Price to Sales (P/S) | 58.11 |
| Price to Book (P/B) | -0.83 |
| EV/EBITDA | -1.85 |
| 50-Day MA | $4.49 |
|---|---|
| 200-Day MA | $7.21 |
| 1-Year Change | −9.12% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Armata Pharmaceuticals at a Glance
As of the Oct 16, 2026 close, Armata Pharmaceuticals (ARMP) has a market capitalization of $191.71M. The stock trades at 58.1× sales. Over the trailing twelve months it lost $192.18M on revenue of $3.30M and burned $25.79M of free cash flow. Revenue fell 36.2% year over year.
As of its latest reported balance sheet, it holds $23.95M in cash and securities against $313.95M of debt, a net debt position of $290.00M.
Armata Pharmaceuticals does not currently pay a dividend.
The share price is down 9.1% over the past year. At $3.37 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $2.75 to $16.34, below its 200-day moving average of $7.21.
Frequently Asked Questions About Armata Pharmaceuticals
What is the current stock price for ARMP?
As of the Oct 16, 2026 close, ARMP stock trades at $3.37. The 52-week range is $2.75–$16.34, with a day range of $2.98–$3.42.
What is the P/E ratio for ARMP?
The P/E ratio (Price-to-Earnings) for ARMP is shown in the Key Statistics section. This valuation metric helps compare Armata Pharmaceuticals, Inc. to industry peers.
Does ARMP pay dividends?
Armata Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ARMP?
Analyst ratings and recommendations for ARMP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ARMP?
As of the Oct 16, 2026 close, Armata Pharmaceuticals's market capitalization is $209.1M, classifying it as a micro-cap company. Armata Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.